Josef Jadassohn (1863–1936), Felix Lewandowsky (1879–1921), and their syndrome by Al Aboud, Ahmad & Al Aboud, Khalid
© 2011 Al Aboud and Al Aboud, publisher and licensee Dove Medical Press Ltd.   This is an Open Access 
article which permits unrestricted noncommercial use, provided the original work is properly cited.
Clinical, Cosmetic and Investigational Dermatology 2011:4 179–182
Clinical, Cosmetic and Investigational Dermatology Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
179
RevIew
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/CCID.S27023
Josef Jadassohn (1863–1936), Felix Lewandowsky  
(1879–1921), and their syndrome
Ahmad Al Aboud1
Khalid Al Aboud2
1Dermatology Department, King 
Abdullah Medical City; 2Dermatology 
Department, King Faisal Hospital, 
Makkah, Saudi Arabia
Correspondence: Khalid Al Aboud 
PO Box 5440, Makkah 21955,  
Saudi Arabia 
email amoa65@hotmail.com
Abstract: Josef Jadassohn (1863–1936) and his assistant, Felix Lewandowsky (1879–1921), 
were eminent German dermatologists who had several dermatology conditions linked 
  eponymously. One such condition is Jadassohn–Lewandowsky syndrome, which is a type of 
pachyonychia congenita – a disease that is characterized by severe thickening of the nail due 
to massive nail hyperkeratosis. This report describes Jadassohn–Lewandowsky syndrome and 
the men behind this disease.
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Introduction
Josef Jadassohn (1863–1936) (Figure 1) was a pioneering German dermatologist1–4 
who, with another great German dermatologist, Felix Lewandowsky (1879–1921)5,6 
(Figure 2), described a syndrome,7 later known as Jadassohn–Lewandowsky 
syndrome.8–15 This report describes Jadassohn–Lewandowsky syndrome and the men 
for whom it is named.
Josef Jadassohn (1863–1936)
Joseph (Josef) Jadassohn was a German dermatologist. Among his many contributions 
to medicine, he is credited for describing several medical conditions,1–4 many of which 
were named after him and his assistants, including nevus sebaceous of Jadassohn, 
Jadassohn–Lewandowsky syndrome, Jadassohn–Dössekker disease (myxoedema 
tuberosum), and Naegeli–Franceschetti–Jadassohn syndrome.2
Jadassohn was born in Liegnitz, Germany on September 10, 1863.1–4 He studied 
medicine in Göttingen, Heidelberg, Leipzig, and Breslau, obtaining his doctorate in 
1887 at Breslau.2 He was an assistant of Albert Neisser at Allerheiligen Hospital in 
Breslau until 1892, the director of the university skin clinic in Bern (1896–1917), and 
a professor of dermatology at Breslau University (1917–1932).1
Jadassohn was a pioneer in the field of allergology and was among the first to take 
an immunological approach in the research of dermatological disorders, contributing 
to the understanding of the immunopathology of tuberculosis and trichophytosis.1 
Jadassohn is credited for introducing patch testing to diagnose contact dermatitis, and 
in 1901, he described a rare childhood dermatological disorder, known as granulosis 
rubra nasi (a papular red lesion of the nose associated with increased sweating).1Clinical, Cosmetic and Investigational Dermatology 2011:4 submit your manuscript | www.dovepress.com
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He was particularly interested in drug reactions, leprosy, 
eczema, tuberculosis, syphilis, and mycotic infections. His 
awareness of the social aspects of venereal diseases led 
to his appointment to the Committee on Hygiene of the 
League of Nations.3 He was a corresponding member of 
the British Association of Dermatology, and in the year 
prior to his death, he was made an honorary fellow of the 
Royal Society of Medicine. Josef Jadassohn died in Zurich 
on March 24, 1936.1,2
Felix Lewandowsky (1879–1921)
Felix Lewandowsky was a Germany dermatologist who is 
credited for describing several medical conditions5,6 that were 
later named after him, including Jadassohn–Lewandowsky 
syndrome, Lewandowsky’s syndrome, and Lewandowsky–
Lutz dysplasia.
Lewandowsky was born on October 1, 1879, and in 
1902, he earned his doctorate at Strassburg.5,6 From 1903 
until 1907 he worked at a dermatology clinic in Bern, where 
he was an assistant to Jadassohn. On returning to Hamburg, 
he worked in Eduard Arning’s (1855–1936) department at 
St George’s Hospital. In 1917, he was appointed director of 
the dermatological clinic at Basel.5,6
Lewandowsky specialized in tuberculosis and infantile 
skin diseases.5 In 1916, he published an important study 
on tuberculosis of the skin, entitled Die Tuberkulose der 
Haut.5,6 Prior to his death, he described epidermodyspla-
sia verruciformis, a rare skin disease, sometimes known 
as Lewandowsky–Lutz dysplasia (named for him and 
dermatologist Wilhelm Lutz).5 Lewandowsky died on 
October 31, 1921.
Jadassohn–Lewandowsky syndrome
Pachyonychia  congenita  (PC)  is  characterized  by 
  onychogryposis, hyperkeratosis of the palms, soles, knees, 
and elbows, tiny cutaneous horns, and leukoplakia of the 
oral mucous membranes. Hyperhidrosis of the hands and 
feet is usually present.12 The hallmark of PC is severe nail 
thickening due to massive nail hyperkeratosis. The Online 
Mendelian   Inheritance in Man® (OMIM®) database contains 
three entries for this disease: PC1 (OMIM #167200), PC2 
(OMIM#167210), and PC recessive (OMIM 260130).
Figure 1 Josef Jadassohn (1863–1936).
Note: Reproduced with permission from Obituary.1
Figure 2 Felix Lewandowsky (1879–1927). 
Note: Reproduced with the kind permission of the Alumni Association of the 
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Jadassohn–Lewandowsky syndrome
PC1 is known as Jadassohn–Lewandowsky type, and PC2 
is called Jackson–Lawler type. PC1 is caused by a mutation 
in KRT6A (located on 12q13.13) and KRT16 (17q21.2). PC2 
is caused by a mutation in KRT6B (12q13.13) and KRT16 
(17q21.2).
In PC, the fingernails and toenails become thickened, 
  yellow-gray, and transversely overcurved with marked sub-
ungual hyperkeratosis, most notably at the distal end. Nail 
trimming is impossible, because the nails are extremely 
hard.14 These abnormalities usually develop during childhood, 
but late-onset PC has been described. Focal palmoplantar 
keratoderma is associated with these nail changes in 60% of 
patients or can result from mutations without detectable nail 
changes.14 Up to 75% of patients have oral leukokeratosis; 
hyperhidrosis of the palms and soles, follicular keratosis, 
and acral bullae (especially during warmer months) are 
common.
PC that is associated with late symptom onset has been 
described by several groups and is called pachyonychia 
congenita tarda, type 1.12
PC1 is considered as a type of keratoderma that princi-
pally involves the plantar surfaces. Onset of plantar calluses 
can be delayed up to 7 years of age. Nail changes may be 
evident at birth but more commonly develop within the 
first few months of life. They are characterized by upward 
angulation of the distal end of the nail due to subungual 
hyperkeratosis, giving the characteristic “door wedge”   distal 
hyperkeratosis. Calluses develop over the plantar pressure 
points; palmar calluses are not seen except in manual   workers. 
Blistering can occur on walking. Hair abnormalities and 
oral, laryngeal, and follicular hyperkeratosis have also been 
described in PC1.14
Jadassohn and Lewandowsky’s original patient was 
a 15-year-old female who was admitted with fungating 
tuberculosis of the skin. Abnormalities had been present 
since birth, and she also had unusual keratinization of the 
skin and tongue. In their case description, Jadassohn and 
Lewandowsky stated, “The nail plates of all the fingers and 
toes are extremely thickened, and so hard that they cannot 
be cut with scissors; the father has to trim them with a ham-
mer and chisel.”8
The familial nature of this condition was established in 
1921, when Murray documented seven affected persons in 
three generations of a family.8 In a similar report, Kumer 
and Loos described 24 cases in a five-generation family 
in 1935.12
Patients with PC2 tend to have cystic lesions (steatocystoma 
multiplex, vellus hair cysts), which reflects the expression 
of K6b and K17 in adnexal structures. The cystic lesions 
form during childhood and appear progressively. Coarse 
or twisted hair, early primary tooth loss, and natal teeth 
are other   features of PC2, reflecting the expression of the 
affected genes in the hair follicle apparatus and teeth.14 
Approximately 60% of patients have oral keratosis, 16% 
have natal or neonatal teeth, and 10% have angular stomatitis. 
Some patients also develop chronic intraoral candidosis. The 
keratosis requires no treatment, but dental advice should be 
sought regarding natal or neonatal teeth. Laryngeal changes 
that require a tracheostomy for respiratory distress during 
childhood have been reported.12
The incidence of cyst formation and natal teeth is higher 
among PC2 patients, although cysts are more commonly seen 
in PC1 patients (25%–33%). Previously unreported clinical 
features of PC include the development of painful oral and 
nipple lesions during breastfeeding, copious production of 
waxy material in ears, and the inability to walk without an 
ambulatory aid (50%).12
There are several clinical differences between PC1 and 
PC2. PC1 patients develop oral leukokeratosis, whereas those 
with PC2 have natal teeth and epidermoid cysts (cylindromas) 
but no oral leukoplakia. Corneal dystrophy is exclusively 
a feature of PC2. Both disorders are clearly autosomal 
dominant.12 In PC2, the nail thickening and keratosis are less 
severe than in type 1.
Thickened nails can be treated surgically in some 
instances, most frequently warranted in PC1. The localiza-
tion of the four implicated keratins in the nail bed suggests 
that tissue is the chief site of pathology. Affected nails that 
are viewed end-on appear almost normal but have a dense 
wedge of subungual keratin, constituting the focus of nail bed 
disease.13 Treatments for PC are based on focal complaints, 
such as ingrowth and paronychia, but there are no established   
therapies.13
The Pachyonychia Congenita Project is an initiative 
that was established to serve PC patients and their families. 
It provides several services to health care providers that are 
interested in PC. Further information about this project is 
available at http://www.pachyonychia.org/homeScientist.php.
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